First-line docetaxel chemotherapy for castrate-resistant prostate cancer

Tim Robinson, Bernadette Coles, Timothy J. Wilt, Malcolm Mason, Mike Shelley

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: The objective of this review is to assess the comparative effectiveness and toxicity of the chemotherapeutic agent docetaxel for the treatment of castrate resistant prostate cancer.

Original languageEnglish (US)
Article numberCD009654
JournalCochrane Database of Systematic Reviews
Volume2013
Issue number12
DOIs
StatePublished - Dec 30 2013

Fingerprint Dive into the research topics of 'First-line docetaxel chemotherapy for castrate-resistant prostate cancer'. Together they form a unique fingerprint.

Cite this